These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mucociliary and cough clearance as a biomarker for therapeutic development. Bennett WD; Daviskas E; Hasani A; Mortensen J; Fleming J; Scheuch G J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):261-72. PubMed ID: 20804426 [TBL] [Abstract][Full Text] [Related]
4. The pharmacologic approach to airway clearance: mucoactive agents. Rubin BK Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570 [TBL] [Abstract][Full Text] [Related]
5. [Bronchial clearance]. Köhler D; Vastag E Pneumologie; 1991 May; 45(5):314-32. PubMed ID: 1857687 [No Abstract] [Full Text] [Related]
6. Mucociliary clearance in the airways. Wanner A; Salathé M; O'Riordan TG Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1868-902. PubMed ID: 8970383 [No Abstract] [Full Text] [Related]
7. Pharmacotherapy of impaired mucociliary clearance in non-CF pediatric lung disease. A review of the literature. Boogaard R; de Jongste JC; Merkus PJ Pediatr Pulmonol; 2007 Nov; 42(11):989-1001. PubMed ID: 17902149 [TBL] [Abstract][Full Text] [Related]
8. Theory and practice of the use of expectorants reviewed from clinical aspects. Nagy G Ther Hung; 1984; 32(1):6-12. PubMed ID: 6400475 [No Abstract] [Full Text] [Related]
10. [Expectorants: an expensive, mostly ineffective therapy of chronic cough]. Medici TC; Züllig A; Schmid A Schweiz Rundsch Med Prax; 1988 Sep; 77(39):1048-54. PubMed ID: 3051267 [No Abstract] [Full Text] [Related]
11. [The use of mucosolvan in ENT diseases. Part I]. Szmeja Z; Golusiński W; Szyfter W; Kruk-Zagajewska A; Mielcarek-Kuchta D Otolaryngol Pol; 1996; 50(2):162-8. PubMed ID: 9045148 [TBL] [Abstract][Full Text] [Related]
12. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis. Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593 [TBL] [Abstract][Full Text] [Related]
13. Erdosteine: Drug exhibiting polypharmacy for the treatment of respiratory diseases. Dal Negro R; Pozzi E; Cella SG Pulm Pharmacol Ther; 2018 Dec; 53():80-85. PubMed ID: 30352285 [TBL] [Abstract][Full Text] [Related]
15. Aerosol Medications for Treatment of Mucus Clearance Disorders. Rubin BK Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577 [TBL] [Abstract][Full Text] [Related]
16. [Ciliary movement and radioisotopic parameters of the mucociliary function in respiratory pathology]. Carratù L; Sofia M; Molino A; Mormile M; Di Benedetto G; Stanziola A Arch Monaldi Mal Torace; 1989; 44(4-6):471-5. PubMed ID: 2577760 [No Abstract] [Full Text] [Related]
17. [Therapeutic possibilities in chronic non-specific respiratory tract diseases. 1. Modification of secretion, inhalation- and respiration therapy, therapy of bronchial obstruction]. Löllgen H; Löllgen-Horres I; von Nieding G Fortschr Med; 1976 Aug; 94(24):1276-84. PubMed ID: 786833 [No Abstract] [Full Text] [Related]
18. Mucociliary clearance in the lung. Mortensen J Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):9-17. PubMed ID: 2075343 [No Abstract] [Full Text] [Related]
19. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection. Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765 [TBL] [Abstract][Full Text] [Related]
20. Methods for clinical assessment of expectorants: a critical review. Lurie A; Mestiri M; Huchon G; Marsac J; Lockhart A; Strauch G; Bergogne-Berezin E; Bignon J; Carbon C; Chwalow J Int J Clin Pharmacol Res; 1992; 12(1):47-52. PubMed ID: 1526698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]